BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 28489996)

  • 1. Cancer-Associated Mutations in Endometriosis without Cancer.
    Anglesio MS; Papadopoulos N; Ayhan A; Nazeran TM; Noë M; Horlings HM; Lum A; Jones S; Senz J; Seckin T; Ho J; Wu RC; Lac V; Ogawa H; Tessier-Cloutier B; Alhassan R; Wang A; Wang Y; Cohen JD; Wong F; Hasanovic A; Orr N; Zhang M; Popoli M; McMahon W; Wood LD; Mattox A; Allaire C; Segars J; Williams C; Tomasetti C; Boyd N; Kinzler KW; Gilks CB; Diaz L; Wang TL; Vogelstein B; Yong PJ; Huntsman DG; Shih IM
    N Engl J Med; 2017 May; 376(19):1835-1848. PubMed ID: 28489996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis.
    Zou Y; Zhou JY; Guo JB; Wang LQ; Luo Y; Zhang ZY; Liu FY; Tan J; Wang F; Huang OP
    Mutat Res; 2018 May; 809():1-5. PubMed ID: 29547736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium.
    Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Tamura R; Mori Y; Yamawaki K; Adachi S; Takahashi T; Kase H; Tanaka K; Yamamoto T; Motoyama T; Inoue I; Enomoto T
    Cell Rep; 2018 Aug; 24(7):1777-1789. PubMed ID: 30110635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic endometriosis harbors somatic cancer-driver mutations.
    Lac V; Verhoef L; Aguirre-Hernandez R; Nazeran TM; Tessier-Cloutier B; Praetorius T; Orr NL; Noga H; Lum A; Khattra J; Prentice LM; Co D; Köbel M; Mijatovic V; Lee AF; Pasternak J; Bleeker MC; Krämer B; Brucker SY; Kommoss F; Kommoss S; Horlings HM; Yong PJ; Huntsman DG; Anglesio MS
    Hum Reprod; 2019 Jan; 34(1):69-78. PubMed ID: 30428062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium.
    Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Adachi S; Kase H; Motoyama T; Inoue I; Enomoto T
    Hum Reprod; 2019 Oct; 34(10):1899-1905. PubMed ID: 31621846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
    Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
    J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology.
    Guo SW
    Hum Reprod Update; 2020 Apr; 26(3):423-449. PubMed ID: 32154564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing the progression of an endometrioma: Benign or malignant?
    Bastu E; Onder S; Demiral I; Ozsurmeli M; Keskin G; Takmaz O; Ozaltin S; Gorgen H; Gungor M; Yavuz E; Buyru F
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():79-84. PubMed ID: 30245441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.
    Anglesio MS; Bashashati A; Wang YK; Senz J; Ha G; Yang W; Aniba MR; Prentice LM; Farahani H; Li Chang H; Karnezis AN; Marra MA; Yong PJ; Hirst M; Gilks B; Shah SP; Huntsman DG
    J Pathol; 2015 Jun; 236(2):201-9. PubMed ID: 25692284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial Cells of Deep Infiltrating Endometriosis Harbor Mutations in Cancer Driver Genes.
    Koppolu A; Maksym RB; Paskal W; Machnicki M; Rak B; Pępek M; Garbicz F; Pełka K; Kuśmierczyk Z; Jacko J; Rydzanicz M; Banach-Orłowska M; Stokłosa T; Płoski R; Malejczyk J; Włodarski PK
    Cells; 2021 Mar; 10(4):. PubMed ID: 33805315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing.
    Shibuya Y; Tokunaga H; Saito S; Shimokawa K; Katsuoka F; Bin L; Kojima K; Nagasaki M; Yamamoto M; Yaegashi N; Yasuda J
    Genes Chromosomes Cancer; 2018 Feb; 57(2):51-60. PubMed ID: 29044863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenomyosis pathogenesis: insights from next-generation sequencing.
    Bulun SE; Yildiz S; Adli M; Wei JJ
    Hum Reprod Update; 2021 Oct; 27(6):1086-1097. PubMed ID: 34131719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis.
    Suda K; Cruz Diaz LA; Yoshihara K; Nakaoka H; Yachida N; Motoyama T; Inoue I; Enomoto T
    Cancer Sci; 2020 Aug; 111(8):3000-3009. PubMed ID: 32473611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma.
    Murakami K; Kanto A; Sakai K; Miyagawa C; Takaya H; Nakai H; Kotani Y; Nishio K; Matsumura N
    Mod Pathol; 2021 Nov; 34(11):2071-2079. PubMed ID: 34172890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.
    Yamamoto S; Tsuda H; Takano M; Tamai S; Matsubara O
    Mod Pathol; 2012 Apr; 25(4):615-24. PubMed ID: 22157930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic mutations in histologically normal endometrium: the new normal?
    Lac V; Nazeran TM; Tessier-Cloutier B; Aguirre-Hernandez R; Albert A; Lum A; Khattra J; Praetorius T; Mason M; Chiu D; Köbel M; Yong PJ; Gilks BC; Anglesio MS; Huntsman DG
    J Pathol; 2019 Oct; 249(2):173-181. PubMed ID: 31187483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
    Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
    Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
    Chakrabarty S; Varghese VK; Sahu P; Jayaram P; Shivakumar BM; Pai CG; Satyamoorthy K
    Br J Cancer; 2017 Jun; 117(1):136-143. PubMed ID: 28524162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Partial) Loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes.
    Borrelli GM; Abrão MS; Taube ET; Darb-Esfahani S; Köhler C; Chiantera V; Mechsner S
    Mol Hum Reprod; 2016 May; 22(5):329-37. PubMed ID: 26832958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS mutations and endometriosis burden of disease.
    Orr NL; Albert A; Liu YD; Lum A; Hong J; Ionescu CL; Senz J; Nazeran TM; Lee AF; Noga H; Lawrenson K; Allaire C; Williams C; Bedaiwy MA; Anglesio MS; Yong PJ
    J Pathol Clin Res; 2023 Jul; 9(4):302-312. PubMed ID: 36977195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.